PlainRecalls
FDA Drug Moderate Class II Terminated

Pantoprazole Sodium for Injection 40mg per vial, Single dose vials NDC 71839-122-01 Packaged as (a) 10 Single-dose vials, NDC 71839-122-10; (b) 25 Single-dose vials, NDC 71839-122-25; Rx Only, Mfd. in India for and Distributed by: BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511.

Reported: September 20, 2023 Initiated: September 5, 2023 #D-1148-2023

Product Description

Pantoprazole Sodium for Injection 40mg per vial, Single dose vials NDC 71839-122-01 Packaged as (a) 10 Single-dose vials, NDC 71839-122-10; (b) 25 Single-dose vials, NDC 71839-122-25; Rx Only, Mfd. in India for and Distributed by: BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511.

Reason for Recall

Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.

Details

Recalling Firm
BE PHARMACEUTICALS AG
Units Affected
41,148 vials
Distribution
Nationwide in the USA
Location
Zug

Frequently Asked Questions

What product was recalled?
Pantoprazole Sodium for Injection 40mg per vial, Single dose vials NDC 71839-122-01 Packaged as (a) 10 Single-dose vials, NDC 71839-122-10; (b) 25 Single-dose vials, NDC 71839-122-25; Rx Only, Mfd. in India for and Distributed by: BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511.. Recalled by BE PHARMACEUTICALS AG. Units affected: 41,148 vials.
Why was this product recalled?
Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 20, 2023. Severity: Moderate. Recall number: D-1148-2023.